Table 2.
Quantitative Data in Eyes Affected by Branch Retinal Vein Occlusion With or Without Peripheral Capillary Nonperfusion
| BRVO | ||
|---|---|---|
| Parameter | No Peripheral Capillary Nonperfusion | Yes Peripheral Capillary Nonperfusion |
| Group number | 1 | 2 |
| Age | 65 ± 10 | 62 ± 8 |
| P = 0.23 | ||
| Collateral vessels extension (µm2) | 113.27 ± 107.85 | 115.43 ± 82.02 |
| P = 0.94 | ||
| Baseline LogMAR BCVA | 0.37 ± 0.25 | 0.43 ± 0.25 |
| P = 0.03* | ||
| Final LogMAR BCVA | 0.17 ± 0.22 | 0.23 ± 0.22 |
| P = 0.02* | ||
| Baseline CMT | 486 ± 189 | 475 ± 155 |
| P > 0.05 | ||
| Final CMT | 320 ± 87 | 321 ± 54 |
| P > 0.05 | ||
| mDCP VD | 0.37 ± 0.05 | 0.34 ± 0.02 |
| P = 0.02* | ||
| RPC VD | 0.42 ± 0.02 | 0.40 ± 0.02 |
| P = 0.01* | ||
| nDCP VD | 0.31 ± 0.01 | 0.30 ± 0.01 |
| P = 0.04* | ||
Legend: BRVO, branch retinal vein occlusion; BCVA, best-corrected visual acuity; CMT, central macular thickness; DCP, deep capillary plexus; RCP, radial peripapillary capillaries; VD, vessel density; macular plexa are indicated by “m”, whereas optic nerve head plexa are indicated by “n.” Statistically significant differences are marked by asterisks (*). The extended version of the table is provided in the Supplementary Materials (Supplementary Table S4).